CORD-19:003f719a05b7a35ea4b778ded17cae230f5a0343 / 13079-13411
Annnotations
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T89","span":{"begin":0,"end":332},"obj":"Sentence"}],"text":"A 25-fold molar excess of unlabeled homologous RNA resulted in an efficient competition of all complexes (Fig. 4A, lane 3) , while the addition of 25-fold molar excess of the unlabeled 3 0 UTR (heterologous RNA) was able to compete efficiently with all complexes, except complex II, which did not compete at all (Fig. 4A, lane 4) ."}
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T89","span":{"begin":0,"end":332},"obj":"Sentence"},{"id":"TextSentencer_T89","span":{"begin":0,"end":332},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A 25-fold molar excess of unlabeled homologous RNA resulted in an efficient competition of all complexes (Fig. 4A, lane 3) , while the addition of 25-fold molar excess of the unlabeled 3 0 UTR (heterologous RNA) was able to compete efficiently with all complexes, except complex II, which did not compete at all (Fig. 4A, lane 4) ."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T35","span":{"begin":212,"end":215},"obj":"Disease"}],"attributes":[{"id":"A35","pred":"mondo_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"}],"text":"A 25-fold molar excess of unlabeled homologous RNA resulted in an efficient competition of all complexes (Fig. 4A, lane 3) , while the addition of 25-fold molar excess of the unlabeled 3 0 UTR (heterologous RNA) was able to compete efficiently with all complexes, except complex II, which did not compete at all (Fig. 4A, lane 4) ."}